-
公开(公告)号:US20210095340A1
公开(公告)日:2021-04-01
申请号:US17122397
申请日:2020-12-15
Applicant: The Chinese University of Hong Kong
Inventor: Yuk-Ming Dennis Lo , Wai Kwun Rossa Chiu , Kwan Chee Chan , Tak Yeung Leung , Peiyong Jiang
IPC: C12Q1/6881 , G16B20/00
Abstract: Methods, systems, and apparatus are provided for determining zygosity of a multiple-fetus pregnancy using a biological sample taken from the mother. The fetal and maternal DNA in the sample (e.g. plasma) can be analyzed for a particular chromosomal region to identify genetic differences in the fetuses. For example, a normalized parameter for the measure of a primary or secondary allele can show variances for different chromosomal regions when fetuses are dizygotic. Such a variance can be determined relative to an expected value if the fetuses were genetically identical. Statistical methods are provided for analyzing the variation of the normalized parameters to determine fetal DNA concentration and the maternal-fetal mixed genotype at various loci. Parental genotype and haplotype information can also be used to identify inheritance of different parental haplotypes to indicate genetic differences among the fetuses.
-
92.
公开(公告)号:US20210090687A1
公开(公告)日:2021-03-25
申请号:US16985980
申请日:2020-08-05
Applicant: Good Start Genetics, Inc
Inventor: Mark UMBARGER , Athurva GORE , Gregory PORRECA
IPC: G16B30/00 , C12Q1/6809 , C12Q1/6827 , C12Q1/6883 , C12Q1/6881
Abstract: The present invention provides methods for validating results of a pre-implantation genetic screen. Methods of the invention increase the efficacy of the common PGS assay FAST-SeqS by taking advantage of single-nucleotide polymorphisms (SNPs) generated from the assay to confirm copy number calls, detect errors, identify samples, and recognize and identify sources of contamination. Methods of the invention increase the reliability of a PGS result, thereby making embryo selection more precise and improving outcomes of in vitro fertilization.
-
公开(公告)号:US20210087619A1
公开(公告)日:2021-03-25
申请号:US16478786
申请日:2019-06-07
Applicant: Monoquant Pty Ltd.
Inventor: Alexander Alan Morley
IPC: C12Q1/6858 , C12Q1/6881 , C12Q1/6886
Abstract: The present invention relates generally to an improved method of amplifying a nucleic acid region of interest and to primers for use therein. More particularly, the present invention is directed to an improved method of amplifying a nucleic acid region which has resulted from the recombination of two or more immunoglobulin or T cell receptor gene segments and primers for use therein. The method of the present invention is based on the determination that performing the amplification step at an annealing temperature determined relative to the critical annealing temperature unique to a given reaction and/or using optimised primers enables higher levels of sensitivity than have previously been achievable in the context of prior art methods of amplifying rearranged immunological or T cell receptor genes. The method of the present invention is particularly useful where the subject recombination target comprises only one N region. The provision of a highly sensitive yet simple means of detecting specific immunological and T cell receptor nucleic acid recombination events is useful in a range of applications including, but not limited to, the diagnosis and/or monitoring of clonal lymphoid cell populations or disease conditions which are characterised by specific V/D/J recombination events (such as detecting minimal residual disease in leukaemias) or the analysis or identification of immunological or T cell receptor gene regions of interest.
-
公开(公告)号:US10947589B2
公开(公告)日:2021-03-16
申请号:US15063278
申请日:2016-03-07
Applicant: Cold Spring Harbor Laboratory
Inventor: James Hicks , Nicholas Navin , Jennifer Troge , Zihua Wang , Michael Wigler
IPC: C12P19/34 , C12Q1/6874 , G16B25/00 , C12Q1/6886 , C12Q1/683 , C12Q1/6881
Abstract: A method for obtaining from genomic material genomic copy number information unaffected by amplification distortion, comprising obtaining segments of the genomic material, tagging the segments with substantially unique tags to generate tagged nucleic acid molecules, such that each tagged nucleic acid molecule comprises one segment of the genomic material and a tag, subjecting the tagged nucleic acid molecules to amplification by polymerase chain reaction (PCR), generating tag associated sequence reads by sequencing the product of the PCR reaction, assigning each tagged nucleic acid molecule to a location on a genome associated with the genomic material by mapping the subsequence of each tag associated sequence read corresponding to a segment of the genomic material to a location on the genome, and counting the number of tagged nucleic acid molecules having a different tag that have been assigned to the same location on the genome, thereby obtaining genomic copy number information unaffected by amplification distortion.
-
公开(公告)号:US20210062153A1
公开(公告)日:2021-03-04
申请号:US16900970
申请日:2020-06-14
Applicant: University Health Network
Inventor: Gordon Keller , Alec Drake Witty , Steven James Kattman
IPC: C12N5/077 , C12Q1/6881 , G01N33/50
Abstract: Methods and products for obtaining cardiovascular lineage cells from hPSCs. The method comprises one or more of the following steps: (a) contacting BMP component primed hPSCs with a cardiovascular mesoderm programming cocktail and culturing the contacted hPSCs for a period of time to generate a KDR+ and PDGFRalpha+ cardiovascular mesoderm cell population; (b) contacting the cardiovascular mesoderm cell population with a cardiovascular progenitor specification cocktail and culturing the contacted cardiovascular mesoderm cell population for a period of time to generate a NKX2-5+ or WT1+ cardiovascular progenitor cell population; and (c) contacting the cardiovascular progenitor cell population with a maturation cocktail and culturing the contacted cardiovascular progenitor population for a period of time to produce a cardiovascular population optionally cardiomyocyte lineage cells expressing cardiac troponin T (cTnT) and/or SIRPA and/or epicardial lineage cells expressing WT1.
-
公开(公告)号:US10920273B2
公开(公告)日:2021-02-16
申请号:US15873862
申请日:2018-01-17
Applicant: Life Technologies Corporation
Inventor: Timothy Looney , Geoffrey Lowman , Lifeng Lin
IPC: C40B50/06 , C12Q1/6876 , C12Q1/6869 , C12Q1/6844 , C12Q1/6811 , C12Q1/6881 , C12Q1/6883 , C07K14/725
Abstract: The present disclosure provides methods, compositions, kits, and systems useful in the determination and evaluation of the immune repertoire. In one aspect, target-specific primer panels provide for the effective amplification of sequences of T cell receptor and/or B cell receptor chains with improved sequencing accuracy and resolution over the repertoire. Variable regions associated with the immune cell receptor are resolved to effectively portray clonal diversity of a biological sample and/or differences associated with the immune cell repertoire of a biological sample.
-
公开(公告)号:US10900080B2
公开(公告)日:2021-01-26
申请号:US13405073
申请日:2012-02-24
Applicant: Yuk Ming Dennis Lo , Wai Kwun Rossa Chu , Kwan Chee Chan , Tak Yeung Leung , Peiyong Jiang
Inventor: Yuk Ming Dennis Lo , Wai Kwun Rossa Chu , Kwan Chee Chan , Tak Yeung Leung , Peiyong Jiang
IPC: C12Q1/6881 , G16B40/00 , G16B20/00
Abstract: Methods, systems, and apparatus are provided for determining zygosity of a multiple-fetus pregnancy using a biological sample taken from the mother. The fetal and maternal DNA in the sample (e.g. plasma) can be analyzed for a particular chromosomal region to identify genetic differences in the fetuses. For example, a normalized parameter for the measure of a primary or secondary allele can show variances for different chromosomal regions when fetuses are dizygotic. Such a variance can be determined relative to an expected value if the fetuses were genetically identical. Statistical methods are provided for analyzing the variation of the normalized parameters to determine fetal DNA concentration and the maternal-fetal mixed genotype at various loci. Parental genotype and haplotype information can also be used to identify inheritance of different parental haplotypes to indicate genetic differences among the fetuses.
-
公开(公告)号:US20210009946A1
公开(公告)日:2021-01-14
申请号:US16755370
申请日:2018-10-15
Applicant: NIBEC CO., LTD. , CHUNGBUK NATIONAL UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION , SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
Inventor: Yoon Shin Park , Yoon Jeong Park , Chong-Pyoung Chung , Jue-Yeon Lee , Da Hyeon Choi
IPC: C12N5/074 , C12N15/115 , C12N5/00 , C12Q1/6881 , C12Q1/686 , C07K16/28 , G01N33/68
Abstract: The present invention relates to a method of screening highly efficiently stem cells using the protein marker GRP78, and more particularly, to a method of removing old stem cells with decreased expression of GRP78 and isolating only highly efficient stem cells. The use of the protein marker GRP78 according to the present invention makes it possible to isolate only highly efficient stem cells by removing old stem cells. Thus, the protein marker GRP78 may be used as an effective marker for controlling the quality of stem cell therapy products and evaluating the stability and effectiveness thereof, and is useful in the production of stem cell therapy products having excellent therapeutic efficacy.
-
公开(公告)号:US10889860B2
公开(公告)日:2021-01-12
申请号:US15023552
申请日:2013-09-24
Applicant: Georgetown University
Inventor: Jennifer Ng , Carolyn K. Hurley , Bin Tu , Carly Masaberg
IPC: C12Q1/68 , C12Q1/6881
Abstract: Provided are methods, kits, and systems useful in the performance of analysis and reporting of highly polymorphic loci, including, in particular, the performance of analysis and reporting of HLA typing. Combining one-step sequencing and sequence-specific oligonucleotide probe hybridization, the methods, kits, and systems offer improved efficiency of HLA typing while providing detailed sequencing information. In certain embodiments the methods and systems comprise one or more software applications to facilitate data acquisition, processing, and reporting.
-
100.
公开(公告)号:US10881690B2
公开(公告)日:2021-01-05
申请号:US16905530
申请日:2020-06-18
Applicant: Immatics Biotechnologies GmbH
Inventor: Heiko Schuster , Janet Peper , Philipp Wagner , Hans-Georg Rammensee
IPC: A61K39/00 , A61K35/17 , C07K7/06 , C07K7/08 , C07K14/47 , C07K14/725 , C07K16/30 , C12N15/115 , C12P21/02 , C12Q1/6881 , C12Q1/6886 , G01N33/574
Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
-
-
-
-
-
-
-
-
-